rel-(2R,3R)-2,3-dihydroxy-4-oxo-4-(6,7,9,10-tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxalin-8-yl)butanoate, sodium salt (1:1)
Varenicline DL-Tartaramide Sodium Salt is a fully characterized chemical compound used as a reference standard of API Varenicline. The standard offered is compliant with regulatory guidelines. Varenicline DL-Tartaramide Sodium Salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
